‘Extraordinary’ for Australia: Murtagh translated to Mandarin The translated ‘bible’ is set to strengthen Australian general practice’s international standing and improve collaboration.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
‘Strong concerns’: ACCC queries pathology merger bid The regulator has said a proposed takeover of Healius by ACL, a move opposed by the RACGP, could have an adverse effect on patients.
More respect needed for ‘Craft of Generalism’: GP A prominent general practice academic says there is an urgent need to clarify the value and expertise of generalist approaches in healthcare.
Pharmacy green light for insulin swap due to shortage Pharmacists have been given permission to substitute a type of insulin pen due to ongoing supply issues that will likely last well into 2024.
Plea for change amid rising life expectancies GPs are calling for a shift in the way elderly patients are cared for, as new data sheds light on our ageing population.
GPs key for equitable access to glucose monitors: RACGP An ongoing NDSS review has sparked renewed calls to allow GPs to certify patients with diabetes for access to subsidised continuous glucose monitors.
Australian Prescriber makes its comeback The publication, which had an uncertain future following funding cuts to its previous publisher NPS MedicineWise, is going out to readers once again.
‘A very challenging space’: Opioid deprescribing guide released Work for guidelines was led by researchers at the University of Sydney and includes 11 recommendations with general practice in mind.
‘A major public health crisis’: Diabetes policy under scrutiny Could a new Parliamentary Inquiry help address gaps in knowledge about the disease, as well as improve policy?